Literature DB >> 26118715

Depletion of mitoferrins leads to mitochondrial dysfunction and impairment of adipogenic differentiation in 3T3-L1 preadipocytes.

Y-C Chen1, Y-T Wu1,2, Y-H Wei1,2,3.   

Abstract

Dysregulation of iron homeostasis is a potential risk factor for type 2 diabetes mellitus (T2DM) and insulin resistance. Iron transported into mitochondria by mitoferrins is mainly utilized for the biosynthesis of iron-sulfur clusters, heme, and other cofactors. Recent studies revealed that mitochondrial dysfunction leads to impaired adipogenesis and insulin insensitivity in adipocytes. However, it is unknown whether mitochondrial iron import and iron status affect the biogenesis and function of mitochondria during adipogenic differentiation. In this study, we used double knockdown of mitoferrin 1 and mitoferrin 2 (Mfrn1/2) to investigate the role of mitochondrial iron homeostasis in mitochondrial bioenergetic function and adipogenic differentiation. The results showed that depletion of Mfrn1/2 in 3T3-L1 preadipocytes impaired the biosynthesis of iron-sulfur proteins in mitochondria due to a decrease in mitochondrial iron content. This was associated with a decrease in mitochondrial oxygen consumption rate and intracellular ATP level in adipocytes with Mfrn1/2 knockdown. Remarkably, Mfrn1/2 deficiency reduced the expression of adipogenic genes and lipid production during adipogenic differentiation. Moreover, insulin-induced glucose uptake and Akt phosphorylation at the Ser473 residue were decreased concurrently in adipocytes differentiated from 3T3-L1 preadipocytes after knockdown of Mfrn1/2. These findings suggest that dysregulation of mitochondrial iron metabolism elicited by knockdown of Mfrn1/2 results in mitochondrial dysfunction, which culminates in the compromise of differentiation and insulin insensitivity of adipocytes. This scenario may explain the recent findings that iron deficiency or alterations in iron metabolism are associated with the pathogenesis of T2DM.

Entities:  

Keywords:  insulin resistance; iron homeostasis; iron–sulfur protein; mitochondria; type 2 diabetes mellitus

Mesh:

Substances:

Year:  2015        PMID: 26118715     DOI: 10.3109/10715762.2015.1067695

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  5 in total

Review 1.  Mitochondrial Iron in Human Health and Disease.

Authors:  Diane M Ward; Suzanne M Cloonan
Journal:  Annu Rev Physiol       Date:  2018-11-28       Impact factor: 19.318

2.  The mitochondrial metal transporters mitoferrin1 and mitoferrin2 are required for liver regeneration and cell proliferation in mice.

Authors:  Alexandra Seguin; Xuan Jia; Aubree M Earl; Liangtao Li; Jared Wallace; Andong Qiu; Thomas Bradley; Rishna Shrestha; Marie-Bérengère Troadec; Matt Hockin; Simon Titen; Dave E Warner; P Tom Dowdle; Martin E Wohlfahrt; Elaine Hillas; Matthew A Firpo; John D Phillips; Jerry Kaplan; Barry H Paw; Jonathan Barasch; Diane M Ward
Journal:  J Biol Chem       Date:  2020-06-09       Impact factor: 5.157

3.  Mitochondrial metabolism is a key regulator of the fibro-inflammatory and adipogenic stromal subpopulations in white adipose tissue.

Authors:  Nolwenn Joffin; Vivian A Paschoal; Christy M Gliniak; Clair Crewe; Abdallah Elnwasany; Luke I Szweda; Qianbin Zhang; Chelsea Hepler; Christine M Kusminski; Ruth Gordillo; Da Young Oh; Rana K Gupta; Philipp E Scherer
Journal:  Cell Stem Cell       Date:  2021-02-03       Impact factor: 24.633

4.  Structural and pharmacological basis for the induction of mitochondrial biogenesis by formoterol but not clenbuterol.

Authors:  Robert B Cameron; Yuri K Peterson; Craig C Beeson; Rick G Schnellmann
Journal:  Sci Rep       Date:  2017-09-05       Impact factor: 4.379

5.  FAM3A enhances adipogenesis of 3T3-L1 preadipocytes via activation of ATP-P2 receptor-Akt signaling pathway.

Authors:  Yujing Chi; Jing Li; Na Li; Zhenzhen Chen; Liping Ma; Weikang Peng; Xiuying Pan; Mei Li; Weidong Yu; Xiangjun He; Bin Geng; Qinghua Cui; Yulan Liu; Jichun Yang
Journal:  Oncotarget       Date:  2017-07-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.